Advanced Medical Strategies Announces Partnership with OptiMed Health Partners
Source: Advanced Medical Strategies, 9/24/2020
Lynnfield, MA – AMS (Advanced Medical Strategies), the leading healthcare IT platform that provides clinical insights and financial analysis of the costliest and most complex medical diagnoses, announced a new partnership with OptiMed Health Partners, a national provider of specialty and infused treatments, to provide health plan administrators benchmarked costs for high-cost specialty drugs.
“Across the healthcare marketplace, there is significant waste, substantial clinical mismanagement and complex mergers that create a whirlwind of pricing games and limited access to actual drug prices, particularly with specialty medications,” says Andrew Reeves, CEO of OptiMed Health Partners. “All this contributes to our lack-luster and unsustainable healthcare market.“
Through this strategic partnership, AMS and OptiMed Health Partners provide AMS clients access to the actual price paid charges for specialty drugs. Health plans, TPAs, plan sponsors and carriers can compare billed specialty drug charges against verifiable cost data to establish fair and reasonable reimbursement rates. In addition, AMS clients can directly engage OptiMed through AMS’ PredictRx member portal links in order to reduce costs across specific cases, multiple clients, or their entire book of business.
Specialty medications cost health plans and members more than $160 billion in 2019. While providing necessary relief to those in need, they can cost thousands of dollars per treatment and quickly become financially taxing for employers, third party administrators and members.
“Our business model is to provide clients with the most comprehensive clinical information and financial data available to guide business initiatives. By partnering with OptiMed, we’re able to enhance our offerings by providing access to real financial insight into specialty pharma costs as well as course of action to reduce drug spend immediately,” states Peter Borans, CEO and co-founder of AMS.
Both AMS and OptiMed are dedicated to making healthcare more affordable through AI-driven analytics, specialty drug price transparency, and access to clinical support that drives positive health outcomes.
About AMS
Founded in 2003, AMS (Advanced Medical Strategies) is a healthcare IT company focused on providing clients with payment intelligence that identifies, analyzes and reports on the 5% of members responsible for 50% total medical spend. Our AI-powered Predict Platform combines clinical insights and financial analysis of the costliest and most complex medical diagnoses our clients rely on to guide enterprise-wide initiatives. We believe that “Knowledge is Power”. Contact Stephanie Belschner at stephanie@mdstrat.com and visit www.mdstrat.com.
About OptiMed
OptiMed Health Partners is a national provider of specialty and infused treatments holding multiple accreditations. OptiMed is continuously setting the new benchmark in pharmaceutical pricing transparency, cost containment solutions, and clinical and patient services. Contact Rusti Greis at rgreis@optimedhp.com and visit www.optimedhp.com.